Incorporation of synaptotagmin II to the axolemma of botulinum type-A poisoned mouse motor endings during enhanced quantal acetylcholine release
- PMID: 9666170
- DOI: 10.1016/s0006-8993(98)00475-2
Incorporation of synaptotagmin II to the axolemma of botulinum type-A poisoned mouse motor endings during enhanced quantal acetylcholine release
Abstract
The involvement of terminal sprouts in neurotransmitter release by in vivo botulinum type-A toxin poisoned motor endings was investigated 15 to 40 days after a single injection of the toxin onto the levator auris longus muscle of the mouse. Enhanced quantal acetylcholine release was induced by alpha-latrotoxin or La3+ in conditions that prevent endocytosis, and an antibody directed against the lumenal domain of synaptotagmin II (Syt II) was used in the presence or absence of Triton X-100. We showed that, under resting conditions, the intravesicular domain of Syt II requires Triton X-100 to be labelled, whereas it becomes exposed to the outside of the axolemma of both the original terminal arborization and the newly formed sprouts during enhanced exocytosis. These data were taken to indicate that, when sprouting is prominent, the whole modified terminal arborization, including the original branches and the sprouts, possesses the machinery for Ca2+-independent exocytosis.
Copyright 1998 Elsevier Science B.V. All rights reserved.
Similar articles
-
Mouse motor nerve terminal immunoreactivity to synaptotagmin II during sustained quantal transmitter release.Brain Res. 1995 May 29;681(1-2):213-7. doi: 10.1016/0006-8993(95)00294-z. Brain Res. 1995. PMID: 7552284
-
Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle.Neuromuscul Disord. 1996 May;6(3):177-85. doi: 10.1016/0960-8966(96)00041-7. Neuromuscul Disord. 1996. PMID: 8784806
-
Synaptotagmin II immunoreactivity in normal and botulinum type-A treated mouse motor nerve terminals.Pflugers Arch. 1996;431(6 Suppl 2):R283-4. doi: 10.1007/BF02346379. Pflugers Arch. 1996. PMID: 8739375
-
Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission.J Physiol Paris. 2002 Jan-Mar;96(1-2):105-13. doi: 10.1016/s0928-4257(01)00086-9. J Physiol Paris. 2002. PMID: 11755789 Review.
-
Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins.Headache. 2003 Jul-Aug;43 Suppl 1:S16-24. doi: 10.1046/j.1526-4610.43.7s.4.x. Headache. 2003. PMID: 12887390 Review.
Cited by
-
Distinct muscarinic acetylcholine receptor subtypes contribute to stability and growth, but not compensatory plasticity, of neuromuscular synapses.J Neurosci. 2009 Nov 25;29(47):14942-55. doi: 10.1523/JNEUROSCI.2276-09.2009. J Neurosci. 2009. PMID: 19940190 Free PMC article.
-
Ciliary neurotrophic factor is not required for terminal sprouting and compensatory reinnervation of neuromuscular synapses: re-evaluation of CNTF null mice.Exp Neurol. 2007 Jun;205(2):437-48. doi: 10.1016/j.expneurol.2007.03.011. Epub 2007 Mar 21. Exp Neurol. 2007. PMID: 17445802 Free PMC article.
-
Penelope's web: using alpha-latrotoxin to untangle the mysteries of exocytosis.J Neurochem. 2009 Oct;111(2):275-90. doi: 10.1111/j.1471-4159.2009.06329.x. Epub 2009 Aug 13. J Neurochem. 2009. PMID: 19682210 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous